Hinge Health (NYSE:HNGE) Reaches New 52-Week High - Here's Why

Key Points

• Hinge Health shares reached a new 52-week high of $91.50, with the stock last trading near $89.67 and up 1.3%. Its market capitalization is approximately $7.0 billion.
• The company reported quarterly EPS of $0.59, beating the $0.28 consensus estimate, while revenue rose 53% year over year to $212.82 million. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $98.64.
• Insiders have sold heavily, including major shareholder Insight Holdings’ sale of 181,499 shares and the chairman’s sale of 83,334 shares; insiders sold 3.72 million shares worth about $287.9 million over the past 90 days.

Hinge Health Inc. (NYSE:HNGE - Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as $91.50 and last traded at $89.6720, with a volume of 279554 shares trading hands. The stock had previously closed at $89.33.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Weiss Ratings reissued a "sell (d-)" rating on shares of Hinge Health in a research report on Monday, August 3rd. Canaccord Genuity Group set a $105.00 price target on shares of Hinge Health in a research report on Wednesday, August 5th. Raymond James Financial lifted their price target on Hinge Health from $70.00 to $80.00 and gave the stock an "outperform" rating in a research note on Monday, June 15th. Citigroup restated an "outperform" rating on shares of Hinge Health in a research note on Monday, July 27th. Finally, Citizens Jmp increased their target price on Hinge Health from $96.00 to $107.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 5th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Hinge Health has an average rating of "Moderate Buy" and an average target price of $98.64.

Hinge Health Trading Up 1.3%

The firm has a market cap of $7.00 billion, a P/E ratio of 70.44 and a beta of 1.31. The business's 50-day moving average is $76.22 and its two-hundred day moving average is $55.01.

Hinge Health (NYSE:HNGE - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.59 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.31. The company had revenue of $212.82 million during the quarter. Hinge Health had a return on equity of 65.44% and a net margin of 15.15%.The business's revenue was up 53.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.59 earnings per share. On average, analysts anticipate that Hinge Health Inc. will post 1.37 earnings per share for the current year.

Insider Buying and Selling

In related news, major shareholder Insight Holdings Group, Llc sold 181,499 shares of the business's stock in a transaction that occurred on Thursday, July 9th. The stock was sold at an average price of $90.20, for a total transaction of $16,371,209.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman Gabriel M.I. Mecklenburg sold 83,334 shares of the company's stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $85.05, for a total value of $7,087,556.70. Following the transaction, the chairman owned 83,334 shares of the company's stock, valued at approximately $7,087,556.70. The trade was a 50.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 3,715,194 shares of company stock valued at $287,886,932. Insiders own 18.92% of the company's stock.

Hedge Funds Weigh In On Hinge Health

Several institutional investors have recently modified their holdings of HNGE. Wells Fargo & Company MN lifted its position in Hinge Health by 160.0% in the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company's stock valued at $25,000 after purchasing an additional 336 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Hinge Health in the 4th quarter worth about $26,000. CENTRAL TRUST Co acquired a new stake in shares of Hinge Health in the first quarter valued at approximately $37,000. First Horizon Corp raised its holdings in shares of Hinge Health by 163.9% during the fourth quarter. First Horizon Corp now owns 855 shares of the company's stock valued at $40,000 after buying an additional 531 shares during the last quarter. Finally, High Point Wealth Management LLC bought a new stake in shares of Hinge Health during the fourth quarter valued at approximately $46,000.

About Hinge Health

Hinge Health NYSE: HNGE is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source